Targeting circulating labile heme as a defense strategy against malaria
Life Science Alliance · 2024
DOI: 10.26508/lsa.202302276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Susana Ramos und 17 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Gulbenkian de Ciência, Oeiras, Portugal sramos@igc.gulbenkian.pt. Hauptthemen laut MEDLINE: Malaria, Acute Kidney Injury. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Gulbenkian Foundation, Hungarian National Research, Development, and Innovation Office.
Abstract (Originalsprache)
Severe presentations of malaria emerge as Plasmodium (P.) spp. parasites invade and lyse red blood cells (RBC), producing extracellular hemoglobin (HB), from which labile heme is released. Here, we tested whether scavenging of extracellular HB and/or labile heme, by haptoglobin (HP) and/or hemopexin (HPX), respectively, counter the pathogenesis of severe presentations of malaria. We found that circulating labile heme is an independent risk factor for cerebral and non-cerebral presentations of severe P. falciparum malaria in children. Labile heme was negatively correlated with circulating HP and HPX, which were, however, not risk factors for severe P. falciparum malaria. Genetic Hp and/or Hpx deletion in mice led to labile heme accumulation in plasma and kidneys, upon Plasmodium infection . This was associated with higher incidence of mortality and acute kidney injury (AKI) in ageing but not adult Plasmodium -infected mice, and was corroborated by an inverse correlation between heme and HPX with serological markers of AKI in P. falciparum malaria. In conclusion, HP and HPX act in an age-dependent manner to prevent the pathogenesis of severe presentation of malaria in mice and presumably in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto Gulbenkian de Ciência, Oeiras, Portugal sramos@igc.gulbenkian.pt.
- Instituto Gulbenkian de Ciência, Oeiras, Portugal.
- Hospital Pediátrico David Bernardino, Luanda, Angola.
- Faculdade de Medicina, Universidade Agostinho Neto, Luanda, Angola.
- Department Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
- Instituto Gulbenkian de Ciência, Oeiras, Portugal mpsoares@igc.gulbenkian.pt.
ORCID-Profile: Susana Ramos, Tiago Paixão, Rui Martins, Ana Rita Carlos, Ana Ferreira, Teresa F Pais, Pedro Faísca, Miguel P Soares
Förderung
- Fundação para a Ciência e Tecnologia
- Gulbenkian Foundation
- Hungarian National Research, Development, and Innovation Office
- Academy of Sciences
- Oeiras-ERC Frontier Research Incentive Awards, SymbNET Research
- Congento
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Ramos, S., Jeney, V., Figueiredo, A., Paixão, T., Sambo, M. R., Quinhentos, V., Martins, R., Gouveia, Z., Carlos, A. R., Ferreira, A., Pais, T. F., Lainé, H., Faísca, P., Rebelo, S., Cardoso, S., Tolosano, E., Penha-Gonçalves, C., & Soares, M. P. (2024). Targeting circulating labile heme as a defense strategy against malaria. Life Science Alliance. https://doi.org/10.26508/lsa.202302276
Vancouver
Ramos S, Jeney V, Figueiredo A, Paixão T, Sambo MR, Quinhentos V, et al. Targeting circulating labile heme as a defense strategy against malaria. Life Science Alliance. 2024. doi:10.26508/lsa.202302276
BibTeX
@article{Ramos2024,
author = {Ramos, Susana and Jeney, Viktoria and Figueiredo, Ana and Paixão, Tiago and Sambo, Maria Rosário and Quinhentos, Vatúsia and Martins, Rui and Gouveia, Zélia and Carlos, Ana Rita and Ferreira, Ana and Pais, Teresa F and Lainé, Hugo and Faísca, Pedro and Rebelo, Sofia and Cardoso, Silvia and Tolosano, Emanuela and Penha-Gonçalves, Carlos and Soares, Miguel P},
title = {Targeting circulating labile heme as a defense strategy against malaria},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202302276}
}
EUVIMED